(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Methes Energies International Ltd, Infinity Pharmaceuticals, and Nautilus.

Rank	Financial Asset	Price	Change	Updated (EST)
1	Methes Energies International Ltd (MEIL)	0.06	58.54%	2023-09-29 12:23:09
2	Infinity Pharmaceuticals (INFI)	0.02	34.4%	2023-09-28 21:11:07
3	Nautilus (NLS)	0.85	14.81%	2023-09-29 12:57:32
4	Groupon (GRPN)	14.40	7.83%	2023-09-29 12:12:54
5	BioNTech SE (BNTX)	109.49	7.31%	2023-09-29 12:51:31
6	iShares FTSE EPRA/NAREIT Europe (IFEU)	35.08	7.21%	2023-09-28 19:23:07
7	Nike (NKE)	96.04	7.15%	2023-09-29 12:57:30
8	Magyar Bancorp (MGYR)	10.25	5.67%	2023-09-29 13:17:07
9	Lightbridge Corporation (LTBR)	4.73	5.58%	2023-09-29 09:10:07
10	Walgreens Boots (WBA)	22.07	5.57%	2023-09-29 12:15:44

The three biggest losers today are FibroGen, Ebix, and Carnival.

Rank	Financial Asset	Price	Change	Updated (EST)
1	FibroGen (FGEN)	0.86	-11.04%	2023-09-29 12:12:21
2	Ebix (EBIX)	9.31	-8.81%	2023-09-29 12:12:01
3	Carnival (CCL)	13.28	-8%	2023-09-29 12:53:49
4	Aspen Group (ASPU)	0.17	-7.47%	2023-09-29 12:16:03
5	Carnival Plc (CUK)	11.95	-7.44%	2023-09-29 12:19:53
6	Marchex (MCHX)	1.35	-6.9%	2023-09-29 11:15:07
7	SmileDirectClub (SDC)	0.42	-6.3%	2023-09-29 12:17:35
8	The Intergroup Corporation (INTG)	32.00	-5.88%	2023-09-28 21:23:07
9	Rumble (RUM)	5.07	-5.86%	2023-09-29 12:23:54
10	Norwegian Cruise Line (NCLH)	16.23	-4.2%	2023-09-29 12:14:03

Winners today

1. Methes Energies International Ltd (MEIL) – 58.54%

Methes Energies International Ltd., a renewable energy company, produces and sells biodiesel fuel and biodiesel processing equipment in the United States and Canada. It offers Denami biodiesel processors. The company also produces glycerin and offer services related to the production of biodiesel, as well as purchases and sells feedstock. It sells its products and services to a network of biodiesel fuel producers. The company was founded in 2004 and is headquartered in Las Vegas, Nevada.

NASDAQ ended the session with Methes Energies International Ltd jumping 58.54% to $0.06 on Friday while NASDAQ jumped 0.14% to $13,219.32.

Earnings Per Share

As for profitability, Methes Energies International Ltd has a trailing twelve months EPS of $-0.53.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -61.54%.

Moving Average

Methes Energies International Ltd’s worth is way higher than its 50-day moving average of $0.03 and way above its 200-day moving average of $0.03.

Volume

Today’s last reported volume for Methes Energies International Ltd is 77850 which is 744.26% above its average volume of 9221.

More news about Methes Energies International Ltd.

2. Infinity Pharmaceuticals (INFI) – 34.4%

Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 1/1b clinical trials for the treatment of triple negative breast cancer, solid tumors, and ovarian cancer. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Cambridge, Massachusetts.

NASDAQ ended the session with Infinity Pharmaceuticals jumping 34.4% to $0.02 on Friday while NASDAQ rose 0.14% to $13,219.32.

Earnings Per Share

As for profitability, Infinity Pharmaceuticals has a trailing twelve months EPS of $-0.32.

Moving Average

Infinity Pharmaceuticals’s value is way below its 50-day moving average of $0.09 and way under its 200-day moving average of $0.26.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Infinity Pharmaceuticals’s EBITDA is -6.22.

Volume

Today’s last reported volume for Infinity Pharmaceuticals is 313578 which is 92.11% below its average volume of 3978720.

More news about Infinity Pharmaceuticals.

3. Nautilus (NLS) – 14.81%

Nautilus, Inc., a fitness solutions company, designs, develops, sources, and markets cardio and strength fitness products, and related accessories for consumer use in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company operates through two segments, Direct and Retail. It offers cardio products, exercise bikes, treadmills, ellipticals, home gyms, dumbbells, kettlebells, and barbells primarily under the Nautilus, Bowflex, and Schwinn brands, as well as digital fitness platform under the JRNY brand. In addition, it engages in licensing its brands and intellectual properties. The company offers its products directly to consumers through television advertising, social media, websites, and catalogs; and through a network of retail companies consisting of sporting goods stores, online-only retailers, electronics stores, furniture stores, and large-format and warehouse stores, as well as specialty retailers and independent bike dealers. Nautilus, Inc. was founded in 1986 and is headquartered in Vancouver, Washington.

NYSE ended the session with Nautilus jumping 14.81% to $0.85 on Friday, following the last session’s upward trend. NYSE slid 0.52% to $15,398.21, after two sequential sessions in a row of gains, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, Nautilus has a trailing twelve months EPS of $-1.72.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -63.74%.

More news about Nautilus.

4. Groupon (GRPN) – 7.83%

Groupon, Inc., together with its subsidiaries, operates a marketplace that connects consumers to merchants. It operates in two segments, North America and International. The company sells goods or services on behalf of third-party merchants; and first-party goods inventory. It serves customers through its mobile applications and websites. The company was formerly known as ThePoint.com, Inc. and changed its name to Groupon, Inc. in October 2008. Groupon, Inc. was incorporated in 2008 and is headquartered in Chicago, Illinois.

NASDAQ ended the session with Groupon jumping 7.83% to $14.40 on Friday while NASDAQ rose 0.14% to $13,219.32.

Earnings Per Share

As for profitability, Groupon has a trailing twelve months EPS of $-5.08.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -309.27%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Groupon’s stock is considered to be oversold (<=20).

Sales Growth

Groupon’s sales growth is negative 12.3% for the ongoing quarter and negative 6.7% for the next.

Revenue Growth

Year-on-year quarterly revenue growth declined by 15.7%, now sitting on 543.27M for the twelve trailing months.

Moving Average

Groupon’s worth is way above its 50-day moving average of $9.81 and way higher than its 200-day moving average of $6.88.

More news about Groupon.

5. BioNTech SE (BNTX) – 7.31%

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV 16+ head and neck cancers; BNT115, which is in Phase I clinical trial in ovarian cancer; and BNT116, which is in Phase I clinical trial for non-small cell lung cancer. It also develops BNT122, which is in Phase II clinical trial for first-line melanoma and in Phase I clinical trial to treat multiple solid tumors; BNT131 that is in Phase I clinical trial for multiple solid tumors; and BNT141 and BNT142 that are in Phase I clinical trial to treat multiple solid tumors. In addition, the company develops BNT151, BNT152, and BNT153 to treat solid tumors; BNT211 to treat multiple solid tumors, and BNT221 for pancreatic and other cancers; BNT311 which are in Phase II clinical trial to treat metastatic non-small cell lung cancer and Phase I clinical trial to treat multiple solid tumors; and BNT312, which is in Phase I clinical trial to treat multiple solid tumors, as well as ONC-392, which is in Phase II clinical trial to treat ovarian cancer and Phase I clinical trial to treat multiple solid tumors. Further, it develops BNT321, an IgG1 monoclonal antibody in Phase I clinical trial for pancreatic cancer; BNT411, a small molecule immunomodulator product candidate in Phase I clinical trial for solid tumors; BNT322, which is in Phase I clinical trial for multiple solid tumors; and prophylactic vaccine for shingles, malaria, tuberculosis, HSV-2, and other infectious diseases. The company has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd; and Ryvu Therapeutics S.A. BioNTech SE was incorporated in 2008 and is based in Mainz, Germany.

NASDAQ ended the session with BioNTech SE jumping 7.31% to $109.49 on Friday, following the last session’s downward trend. NASDAQ jumped 0.14% to $13,219.32, after two successive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, BioNTech SE has a trailing twelve months EPS of $18.94.

PE Ratio

BioNTech SE has a trailing twelve months price to earnings ratio of 5.78. Meaning, the purchaser of the share is investing $5.78 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.82%.

Moving Average

BioNTech SE’s worth is below its 50-day moving average of $111.81 and way under its 200-day moving average of $125.21.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BioNTech SE’s stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

BioNTech SE’s stock is valued at $109.49 at 17:32 EST, way under its 52-week high of $188.99 and way higher than its 52-week low of $95.50.

More news about BioNTech SE.

6. iShares FTSE EPRA/NAREIT Europe (IFEU) – 7.21%

NASDAQ ended the session with iShares FTSE EPRA/NAREIT Europe jumping 7.21% to $35.08 on Friday, after five sequential sessions in a row of losses. NASDAQ jumped 0.14% to $13,219.32, after two consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, iShares FTSE EPRA/NAREIT Europe has a trailing twelve months EPS of $3.47.

More news about iShares FTSE EPRA/NAREIT Europe.

7. Nike (NKE) – 7.15%

NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, accessories, and services worldwide. The company provides athletic and casual footwear, apparel, and accessories under the Jumpman trademark; and casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks. It also sells a line of performance equipment and accessories comprising bags, sport balls, socks, eyewear, timepieces, digital devices, bats, gloves, protective equipment, and other equipment for sports activities under the NIKE brand; and various plastic products to other manufacturers. In addition, the company markets apparel with licensed college and professional team, and league logos, as well as sells sports apparel; and licenses unaffiliated parties to manufacture and sell apparel, digital devices, and applications and other equipment for sports activities under NIKE-owned trademarks. It sells its products to footwear stores; sporting goods stores; athletic specialty stores; department stores; skate, tennis, and golf shops; and other retail accounts through NIKE-owned retail stores, digital platforms, independent distributors, licensees, and sales representatives. NIKE, Inc. was founded in 1964 and is headquartered in Beaverton, Oregon.

NYSE ended the session with Nike rising 7.15% to $96.04 on Friday while NYSE fell 0.52% to $15,398.21.

Shares of sports retailers adidas and puma shares surge after Nike resultsAdidas shares jumped 6%, and Puma stock rose 5%, after Nike reported shares also jumped 6% in London.

Nike stock forecast: earnings beat triggers NKE to spike 9%Morgan Stanley analyst Alex Straton retained his $126 price target on Nike shares and his Overweight rating. , Oregon-based Nike reported $0.94 in GAAP earnings per share (EPS) on revenue of $12.94 billion.

Earnings Per Share

As for profitability, Nike has a trailing twelve months EPS of $3.24.

PE Ratio

Nike has a trailing twelve months price to earnings ratio of 29.64. Meaning, the purchaser of the share is investing $29.64 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.62%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 4.8%, now sitting on 51.22B for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Nike’s EBITDA is 133.52.

Volatility

Nike’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.53%, a negative 0.65%, and a positive 1.02%.

Nike’s highest amplitude of average volatility was 0.53% (last week), 0.86% (last month), and 1.02% (last quarter).

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is a negative 24.7% and positive 4.7% for the next.

Previous days news about Nike

Nike (nke) Q1 earnings: taking a look at key metrics versus estimates. According to Zacks on Thursday, 28 September, "Here is how Nike performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
Nike (nke) Q1 earnings beat estimates. According to Zacks on Thursday, 28 September, "While Nike has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"

More news about Nike.

8. Magyar Bancorp (MGYR) – 5.67%

Magyar Bancorp, Inc. operates as the holding company for Magyar Bank that provides various banking services in the United States. It accepts various deposit accounts, including demand, NOW, money market, savings, retirement, and certificates of deposit accounts. The company also offers residential mortgage loans; commercial real estate, commercial business, and construction loans; and consumer loans, which consist of home equity lines of credit and stock-secured demand loans. In addition, it provides non-deposit investment products and financial planning services, including insurance products, fixed and variable annuities, and retirement planning for individual and commercial customers; and buys, sells, and holds investment securities. The company has seven branch offices located in New Brunswick, North Brunswick, South Brunswick, Branchburg, Bridgewater, and Edison, New Jersey; and a loan product office located in Keyport, New Jersey. Magyar Bancorp, Inc. was founded in 1922 and is headquartered in New Brunswick, New Jersey. Magyar Bancorp, Inc. is a subsidiary of Magyar Bancorp, MHC.

NASDAQ ended the session with Magyar Bancorp jumping 5.67% to $10.25 on Friday, after five consecutive sessions in a row of losses. NASDAQ rose 0.14% to $13,219.32, after two sequential sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Magyar Bancorp has a trailing twelve months EPS of $1.2.

PE Ratio

Magyar Bancorp has a trailing twelve months price to earnings ratio of 8.54. Meaning, the purchaser of the share is investing $8.54 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.81%.

More news about Magyar Bancorp.

9. Lightbridge Corporation (LTBR) – 5.58%

Lightbridge Corporation, together with its subsidiaries, develops nuclear fuel technology under the Lightbridge Fuel name. It focuses on developing and commercializing metallic nuclear fuels that could enhance resistance of nuclear fuel in existing and new nuclear reactors with a meaningful impact on addressing climate change and air pollution. The company was formerly known as Thorium Power, Ltd. and changed its name to Lightbridge Corporation in September 2009. Lightbridge Corporation was incorporated in 1992 and is based in Reston, Virginia.

NASDAQ ended the session with Lightbridge Corporation jumping 5.58% to $4.73 on Friday while NASDAQ jumped 0.14% to $13,219.32.

Earnings Per Share

As for profitability, Lightbridge Corporation has a trailing twelve months EPS of $-0.67.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -26.42%.

More news about Lightbridge Corporation.

10. Walgreens Boots (WBA) – 5.57%

Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. The company operates under the Walgreens and Duane Reade brands in the United States. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. The company operates retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.

NASDAQ ended the session with Walgreens Boots jumping 5.57% to $22.07 on Friday, after three sequential sessions in a row of losses. NASDAQ jumped 0.14% to $13,219.32, after two consecutive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Walgreens Boots has a trailing twelve months EPS of $-3.84.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -12.6%.

Yearly Top and Bottom Value

Walgreens Boots’s stock is valued at $22.07 at 17:32 EST, way under its 52-week low of $24.97.

More news about Walgreens Boots.

Losers Today

1. FibroGen (FGEN) – -11.04%

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and Duchenne muscular dystrophy; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

NASDAQ ended the session with FibroGen sliding 11.04% to $0.86 on Friday, after four sequential sessions in a row of gains. NASDAQ jumped 0.14% to $13,219.32, after two sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, FibroGen has a trailing twelve months EPS of $-3.78.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1015.79%.

Yearly Top and Bottom Value

FibroGen’s stock is valued at $0.86 at 17:32 EST, way under its 52-week high of $25.69 and way above its 52-week low of $0.70.

Revenue Growth

Year-on-year quarterly revenue growth grew by 48.7%, now sitting on 130.58M for the twelve trailing months.

Sales Growth

FibroGen’s sales growth is 134.1% for the present quarter and 13.7% for the next.

More news about FibroGen.

2. Ebix (EBIX) – -8.81%

Ebix, Inc., together with its subsidiaries, provides on-demand infrastructure software exchanges and e-commerce services to the insurance, financial, travel, cash remittance, and healthcare industries in the United States and internationally. The company develops and deploys insurance and reinsurance exchanges on an on-demand basis using software-as-a-service (SaaS) enterprise solutions in the areas of customer relationship management, front-end and back-end systems, and outsourced administrative and risk compliance solutions. Its EbixCash exchange related products and services include gift cards; travel exchanges services; money transfer services; foreign exchange and outward remittance services; consumer payment services; and on-demand technology to various providers in the areas of lending, wealth and asset management, and travel. The company's insurance exchanges related products and services include SaaS platform and related services; licensing of software; and professional services comprising setup, customization, training, or consulting. Its risk compliance services cover certificates of insurance creation and tracking; consulting services, such as project management, integration, development, and testing; and business process outsourcing services, including domain intensive project management, system consulting services, and claims adjudication/settlement services. The company was formerly known as Delphi Systems, Inc. and changed its name to Ebix, Inc. in December 2003. Ebix, Inc. was founded in 1976 and is headquartered in Johns Creek, Georgia.

NASDAQ ended the session with Ebix sliding 8.81% to $9.31 on Friday while NASDAQ rose 0.14% to $13,219.32.

Earnings Per Share

As for profitability, Ebix has a trailing twelve months EPS of $1.07.

PE Ratio

Ebix has a trailing twelve months price to earnings ratio of 8.7. Meaning, the purchaser of the share is investing $8.7 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.64%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Ebix’s EBITDA is 1.05.

More news about Ebix.

3. Carnival (CCL) – -8%

Carnival Corporation & plc engages in the provision of leisure travel services. The company operates a fleet of more than 90 ships visit approximately 700 ports under AIDA Cruises, Carnival Cruise Line, Costa Cruises, Cunard, Holland America Line, Princess Cruises, P&O Cruises (Australia), P&O Cruises (UK), and Seabourn brand names. It also provides port destinations and other services, as well as owns and owns and operates hotels, lodges, glass-domed railcars, and motorcoaches. The company sells its cruises primarily through travel agents, tour operators, vacation planners, and websites. It operates in the United States, Canada, Continental Europe, the United Kingdom, Australia, New Zealand, Asia, and internationally. Carnival Corporation & plc was founded in 1972 and is headquartered in Miami, Florida.

NYSE ended the session with Carnival dropping 8% to $13.28 on Friday while NYSE dropped 0.52% to $15,398.21.

Cruise operator Carnival books first quarterly profit since onset of pandemicShares of Carnival Corp. rallied Friday after the cruise operator booked its first quarterly profit since before the COVID pandemic, as significantly elevated demand led to record revenue and bookings., Booking volumes continued at significantly elevated levels, Carnival said, as the company set a new third-quarter record for total bookings.

Carnival (ccl) surpasses Q3 earnings and revenue estimatesWhile Carnival has outperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?

Here's what key metrics tell us about Carnival (ccl) Q3 earningsHere is how Carnival performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

: cruise operators’ stocks are sliding after Carnival warns of rising fuel costsCruise operators’ stocks are slumping after Carnival Corp. on Friday warned of rising fuel prices that impacted the company’s earnings. , While we’ve experienced volatility in fuel prices before, there’s only been one other period in the last 15 years that our fuel price has been this level, Carnival Chief Executive Josh Weinstein told analysts on a conference call.

Earnings Per Share

As for profitability, Carnival has a trailing twelve months EPS of $-2.73.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -49.09%.

More news about Carnival.

4. Aspen Group (ASPU) – -7.47%

Aspen Group, Inc., an education technology company, provides online higher education services in the United States. The company offers baccalaureate, master's, and doctoral degree programs in nursing and health sciences, business and technology, arts and sciences, and education fields through Aspen University and United States University. As of April 30, 2022, it had 13,334 degree-seeking students enrolled. Aspen Group, Inc. was founded in 1987 and is based in New York, New York.

NASDAQ ended the session with Aspen Group falling 7.47% to $0.17 on Friday, following the last session’s upward trend. NASDAQ jumped 0.14% to $13,219.32, after two sequential sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Aspen Group has a trailing twelve months EPS of $-0.36.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Yearly Top and Bottom Value

Aspen Group’s stock is valued at $0.17 at 17:32 EST, way below its 52-week high of $0.89 and way higher than its 52-week low of $0.03.

Volatility

Aspen Group’s last week, last month’s, and last quarter’s current intraday variation average was 0.34%, 1.17%, and 6.52%.

Aspen Group’s highest amplitude of average volatility was 7.95% (last week), 7.82% (last month), and 6.52% (last quarter).

More news about Aspen Group.

5. Carnival Plc (CUK) – -7.44%

NYSE ended the session with Carnival Plc dropping 7.44% to $11.95 on Friday, after two sequential sessions in a row of gains. NYSE slid 0.52% to $15,398.21, after two successive sessions in a row of gains, on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Carnival Plc has a trailing twelve months EPS of $-2.74.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -49.09%.

Moving Average

Carnival Plc’s value is way below its 50-day moving average of $15.62 and way above its 200-day moving average of $10.76.

Volatility

Carnival Plc’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.18%, a negative 0.73%, and a positive 1.93%.

Carnival Plc’s highest amplitude of average volatility was 1.04% (last week), 1.41% (last month), and 1.93% (last quarter).

Sales Growth

Carnival Plc’s sales growth for the current quarter is 72.5%.

More news about Carnival Plc.

6. Marchex (MCHX) – -6.9%

Marchex, Inc. operates as a call analytics company that helps businesses connect, drive, measure, and convert callers into customers. Its products include Marchex Call Analytics, an analytics platform for enterprises that depend on inbound phone calls to drive sales, appointments, and reservations; Marchex Speech Analytics that enable actionable insights for enterprise, mid-sized, and small businesses; Text Analytics and Communications, which enable businesses to send and receive text/SMS messages with customers; Call Monitoring; and Marchex Sales Edge that enable businesses to understand customer conversations in phone calls and text. The company also offers Marchex Omnichannel Analytics Cloud products, such as Marchex Search Analytics, a product for search marketers that drive phone calls from search campaigns; Marchex Display and Video Analytics, a product for marketers that buy digital display advertising; Marchex Site Analytics, a product for marketers that can drive phone calls from Websites; and Marchex Social Analytics, a product for marketers that buy social media advertising. In addition, it provides Marchex Audience Targeting that leverages call data to automatically build audience segments for display and social media platforms; and Marchex Call Marketplace, a mobile advertising network for businesses that depend on inbound phone calls to drive sales, as well as provides advertisers ad placements across various mobile and online media sources to deliver qualified calls to their businesses. In addition, it provides Local Leads platform, a service advertising solution for small business resellers, such as Yellow Pages providers and vertical marketing service providers to sell call advertising, search marketing, and other lead generation products through their existing sales channels to small business advertisers. Marchex, Inc. was founded in 2003 and is headquartered in Seattle, Washington.

NASDAQ ended the session with Marchex sliding 6.9% to $1.35 on Friday, following the last session’s upward trend. NASDAQ rose 0.14% to $13,219.32, after two sequential sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Marchex has a trailing twelve months EPS of $-0.3.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is a negative 200% and positive 60% for the next.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Marchex’s EBITDA is 1.02.

Revenue Growth

Year-on-year quarterly revenue growth declined by 7.3%, now sitting on 50.23M for the twelve trailing months.

More news about Marchex.

7. SmileDirectClub (SDC) – -6.3%

SmileDirectClub, Inc., an oral care company, offers clear aligner therapy treatment. The company manages the end-to-end process, which include marketing, aligner manufacturing, fulfillment, treatment by a customer's dentist or orthodontist, and facilitating remote clinical monitoring through a network of orthodontists and general dentists through its proprietary teledentistry platform, SmileCheck in the United States, Puerto Rico, Canada, Australia, the United Kingdom, New Zealand, Ireland, Hong Kong, Germany, Singapore, France, Spain, and Austria. It also offers aligners, impression and whitening kits, whitening gels, and retainers; and toothbrushes, toothpastes, water flossers, SmileSpa, and various ancillary oral care products. The company was founded in 2014 and is headquartered in Nashville, Tennessee.

NASDAQ ended the session with SmileDirectClub sliding 6.3% to $0.42 on Friday while NASDAQ jumped 0.14% to $13,219.32.

Earnings Per Share

As for profitability, SmileDirectClub has a trailing twelve months EPS of $-2.628.

Revenue Growth

Year-on-year quarterly revenue growth declined by 19.1%, now sitting on 414.88M for the twelve trailing months.

Sales Growth

SmileDirectClub’s sales growth is 10.4% for the current quarter and 26.5% for the next.

Volume

Today’s last reported volume for SmileDirectClub is 404723 which is 81.34% below its average volume of 2169650.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SmileDirectClub’s stock is considered to be overbought (>=80).

More news about SmileDirectClub.

8. The Intergroup Corporation (INTG) – -5.88%

The InterGroup Corporation, through its subsidiaries, operates a hotel under the Hilton San Francisco Financial District name located in San Francisco, California. It operates through three segments: Hotel Operations, Real Estate Operations, and Investment Transactions. The company's hotel consists of 544 guest rooms and luxury suites with approximately 22,000 square feet of meeting room space, grand ballroom, 5 level underground parking garage, pedestrian bridge, and Chinese culture center. As of June 30, 2020, it owned, managed, and invested in real estate consisted of 20 properties, which included 16 apartment complexes, 3 single-family houses as strategic investments, and 1 commercial real estate property located in the United States. In addition, the company invests in multi-family and commercial real estate properties; and owns approximately 2 acres of unimproved land in Maui, Hawaii. Further, it invests in instruments, corporate debt and equity securities, publicly traded investment funds, mortgage backed securities, securities issued by REIT's, and other companies that invest primarily in real estate. The InterGroup Corporation was founded in 1965 and is based in Los Angeles, California.

NASDAQ ended the session with The Intergroup Corporation sliding 5.88% to $32.00 on Friday while NASDAQ rose 0.14% to $13,219.32.

Earnings Per Share

As for profitability, The Intergroup Corporation has a trailing twelve months EPS of $-1.27.

Moving Average

The Intergroup Corporation’s worth is under its 50-day moving average of $34.51 and way under its 200-day moving average of $39.67.

Yearly Top and Bottom Value

The Intergroup Corporation’s stock is valued at $32.00 at 17:32 EST, way below its 52-week high of $56.40 and higher than its 52-week low of $30.00.

Volume

Today’s last reported volume for The Intergroup Corporation is 3659 which is 580.11% above its average volume of 538.

Earnings Before Interest, Taxes, Depreciation, and Amortization

The Intergroup Corporation’s EBITDA is 91.42.

More news about The Intergroup Corporation.

9. Rumble (RUM) – -5.86%

Rumble Inc. operates video sharing platforms in the United States, Canada, and internationally. The company operates rumble.com, a platform where users can subscribe to channels to stay in touch with creators, and access video on-demand (VOD) and live content streamed by creators. It also operates locals.com, a subscription platform for creators and subscribers to engage through VOD, podcasts, live chat, polls, and community discussions; and Rumble Advertising Center (RAC), an online advertising management exchange. The company was founded in 2013 and is headquartered in Longboat Key, Florida.

NASDAQ ended the session with Rumble dropping 5.86% to $5.07 on Friday while NASDAQ rose 0.14% to $13,219.32.

Earnings Per Share

As for profitability, Rumble has a trailing twelve months EPS of $-0.3.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -35.81%.

Moving Average

Rumble’s value is way under its 50-day moving average of $8.31 and way below its 200-day moving average of $8.90.

Revenue Growth

Year-on-year quarterly revenue growth grew by 467.7%, now sitting on 73.53M for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Rumble’s EBITDA is -78.51.

Volatility

Rumble’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.88%, a negative 2.49%, and a positive 2.76%.

Rumble’s highest amplitude of average volatility was 4.15% (last week), 3.98% (last month), and 2.76% (last quarter).

More news about Rumble.

10. Norwegian Cruise Line (NCLH) – -4.2%

Norwegian Cruise Line Holdings Ltd., together with its subsidiaries, operates as a cruise company in North America, Europe, the Asia-Pacific, and internationally. The company operates the Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises brands. It offers itineraries ranging from three days to a 180-days calling on various locations, including destinations in Scandinavia, Russia, the Mediterranean, the Greek Isles, Alaska, Canada and New England, Hawaii, Asia, Tahiti and the South Pacific, Australia and New Zealand, Africa, India, South America, the Panama Canal, and the Caribbean. It distributes its products through retail/travel advisor and onboard cruise sales channels, as well as meetings, incentives, and charters. The company was founded in 1966 and is based in Miami, Florida.

NASDAQ ended the session with Norwegian Cruise Line sliding 4.2% to $16.23 on Friday, after three sequential sessions in a row of gains. NASDAQ jumped 0.14% to $13,219.32, after two successive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, Norwegian Cruise Line has a trailing twelve months EPS of $-2.21.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -185.62%.

Volatility

Norwegian Cruise Line’s last week, last month’s, and last quarter’s current intraday variation average was a positive 1.36%, a negative 0.19%, and a positive 2.10%.

Norwegian Cruise Line’s highest amplitude of average volatility was 3.46% (last week), 2.01% (last month), and 2.10% (last quarter).

More news about Norwegian Cruise Line.

Stay up to date with our winners and losers daily report